Interaction of phytoestrogens with estrogen receptors alpha and beta (II) - PubMed (original) (raw)

Interaction of phytoestrogens with estrogen receptors alpha and beta (II)

Keiko Morito et al. Biol Pharm Bull. 2002 Jan.

Free article

Abstract

We investigated the estrogenic activities of isoflavone derivatives in competition binding assays with human estrogen receptor (hER) alpha or hER beta protein, and in a gene expression assay using a yeast system. Coumestrol binds as strongly as 17beta-estradiol to both hERs. Biochanin A, 5-OMe-genistein, formononetin, and tectorigenin bind well to hER beta, but significant binding to hER alpha is only observed with 5-OMe-genistein, formononetin and tectorigenin. The binding of 7-OMe-genistein and irisolidone is poor to both receptors. Among the glucosides, sissotorin binds both receptors and the binding is stronger than genistin. Coumestrol induces transcription as strongly as genistein. Tectorigenin also induces transcription with both hERs. Though biochanin A, 5-OMe-genistein, 7-OMe-genistein, irisolidone and formononetin slightly induce transcription with hER beta, they act as antagonists in the induction of transcription by 17beta-estradiol. The results show that methylation or glucosidation of isoflavones generally inhibits their phytoestrogenic activities.

PubMed Disclaimer

Similar articles

• Interaction of phytoestrogens with estrogen receptors alpha and beta.
  Morito K, Hirose T, Kinjo J, Hirakawa T, Okawa M, Nohara T, Ogawa S, Inoue S, Muramatsu M, Masamune Y. Morito K, et al. Biol Pharm Bull. 2001 Apr;24(4):351-6. doi: 10.1248/bpb.24.351. Biol Pharm Bull. 2001. PMID: 11305594
• Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta.
  Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, van der Burg B, Gustafsson JA. Kuiper GG, et al. Endocrinology. 1998 Oct;139(10):4252-63. doi: 10.1210/endo.139.10.6216. Endocrinology. 1998. PMID: 9751507
• The estrogenic and antiestrogenic activities of phytochemicals with the human estrogen receptor expressed in yeast.
  Collins BM, McLachlan JA, Arnold SF. Collins BM, et al. Steroids. 1997 Apr;62(4):365-72. doi: 10.1016/s0039-128x(96)00246-2. Steroids. 1997. PMID: 9090797
• [Phytoestrogens].
  Kinjo J. Kinjo J. Nihon Rinsho. 2000 Dec;58(12):2434-8. Nihon Rinsho. 2000. PMID: 11187733 Review. Japanese.
• [The molecular mechanisms of estrogens. Clinical aspects, industrial estrogens and phytoestrogens].
  Hagen ML, Hellmers M, Abrahamsen B, Hagen C. Hagen ML, et al. Ugeskr Laeger. 2004 Mar 22;166(13):1220-4. Ugeskr Laeger. 2004. PMID: 15088482 Review. Danish. No abstract available.

Cited by

• The Pros and Cons of Estrogens in Prostate Cancer: An Update with a Focus on Phytoestrogens.
  Figueira MI, Carvalho TMA, Macário-Monteiro J, Cardoso HJ, Correia S, Vaz CV, Duarte AP, Socorro S. Figueira MI, et al. Biomedicines. 2024 Jul 23;12(8):1636. doi: 10.3390/biomedicines12081636. Biomedicines. 2024. PMID: 39200101 Free PMC article. Review.
• Antidepressant-like effects of the Punica granatum and citalopram combination are associated with structural changes in dendritic spines of granule cells in the dentate gyrus of rats.
  Vega-Rivera NM, González-Trujano ME, Luna-Angula A, Sánchez-Chapul L, Estrada-Camarena E. Vega-Rivera NM, et al. Front Pharmacol. 2023 Oct 13;14:1211663. doi: 10.3389/fphar.2023.1211663. eCollection 2023. Front Pharmacol. 2023. PMID: 37900157 Free PMC article.
• Cytotoxic Compounds from Belamcanda chinensis (L.) DC Induced Apoptosis in Triple-Negative Breast Cancer Cells.
  Guo YP, Yi P, Shi QQ, Yu RR, Wang JH, Li CY, Wu HQ. Guo YP, et al. Molecules. 2023 Jun 12;28(12):4715. doi: 10.3390/molecules28124715. Molecules. 2023. PMID: 37375271 Free PMC article.
• Effects of Isoflavone Supplementation on the Response to Medroxyprogesterone in Premenopausal Women with Nonatypical Endometrial Hyperplasia: A Randomized, Double-Blind, Placebo-Controlled Trial.
  Vahedpour Z, Boroumand H, Tabatabaee Anaraki S, Tabasi Z, Motedayyen H, Akbari H, Raygan F, Ostadmohammadi V. Vahedpour Z, et al. Int J Clin Pract. 2022 Nov 24;2022:1263544. doi: 10.1155/2022/1263544. eCollection 2022. Int J Clin Pract. 2022. PMID: 36531558 Free PMC article. Clinical Trial.
• S-Equol enhances osteoblastic bone formation and prevents bone loss through OPG/RANKL via the PI3K/Akt pathway in streptozotocin-induced diabetic rats.
  Xu Z, Xu J, Li S, Cui H, Zhang G, Ni X, Wang J. Xu Z, et al. Front Nutr. 2022 Oct 21;9:986192. doi: 10.3389/fnut.2022.986192. eCollection 2022. Front Nutr. 2022. PMID: 36337646 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • J-STAGE, Japan Science and Technology Information Aggregator, Electronic

• Other Literature Sources

  • The Lens - Patent Citations